Early recognition of xanthomas in children and adolescents is crucial for diagnosing inherited hyperlipoproteinemias and preventing premature coronary artery disease.
May support lipid screening in children with xanthomas; leaves open prospective validation of CAD prevention.
Early recognition of the hyperlipoproteinemias is a crucial element in preventing premature coronary artery disease. Xanthomas provide a cutaneous marker of the silent, underlying pathology. Identifying them, and understanding their relation to the inherited hyperlipoproteinemias may facilitate early diagnosis of hyperlipoproteinemias in pediatric patients. The dermatologist plays an important role in identifying these lesions and in subsequently facilitating prompt referral and treatment.
No takes yet. Share an insight, caveat, or question.
Maher‐Wiese et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: